Principal Financial Group’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.9M	Sell	162,070 -3,004	-2%	-$799K	0.02%	544
2025 Q4	$40.7M	Buy	165,074 +22,231	+16%	+$4.68M	0.02%	530
2025 Q3	$25.2M	Buy	142,843 +1,960	+1%	+$293K	0.01%	739
2025 Q2	$19.4M	Buy	140,883 +14,546	+12%	+$2.14M	0.01%	860
2025 Q1	$22.8M	Buy	126,337 +2,884	+2%	+$485K	0.01%	742
2024 Q4	$19.3M	Buy	123,453 +3,727	+3%	+$661K	0.01%	869
2024 Q3	$21.8M	Sell	119,726 -3,743	-3%	-$722K	0.01%	789
2024 Q2	$22.7M	Buy	123,469 +117,510	+1,972%	+$19.7M	0.01%	774
2024 Q1	$1.06M	Buy	5,959 +160	+3%	+$22.2K	﹤0.01%	1861
2023 Q4	$719K	Buy	5,799 +31	+0.5%	+$3.44K	﹤0.01%	1882
2023 Q3	$669K	Sell	5,768 -125	-2%	-$15.3K	﹤0.01%	1898
2023 Q2	$692K	Sell	5,893 -240	-4%	-$24.5K	﹤0.01%	1894
2023 Q1	$491K	Buy	6,133 +480	+8%	+$37.7K	﹤0.01%	1967
2022 Q4	$448K	Buy	5,653 +264	+5%	+$19.6K	﹤0.01%	2005
2022 Q3	$376K	Buy	5,389 +749	+16%	+$54.1K	﹤0.01%	2024
2022 Q2	$305K	Buy	+4,640	New	+$289K	﹤0.01%	2173
2021 Q4	–	Sell	-4,356	Closed	-$227K	–	2587
2021 Q3	$227K	Sell	4,356 -704	-14%	-$41.7K	﹤0.01%	2396
2021 Q2	$344K	Sell	5,060 -2,523	-33%	-$176K	﹤0.01%	2313
2021 Q1	$585K	Buy	7,583 +13	+0.2%	+$945	﹤0.01%	2115
2020 Q4	$454K	Buy	+7,570	New	+$378K	﹤0.01%	2136